MDxHealth to Share Financial Insights and Updates Soon
Company to Host Conference Call with Live Q&A
MDxHealth SA (NASDAQ: MDXH), a prominent player in precision diagnostics, is gearing up to unveil its financial results for the fourth quarter and the full year that closed on December 31, 2024. The announcement is scheduled for February 26, 2025, making it an eagerly anticipated event among investors and stakeholders.
Details of the Upcoming Conference Call
The conference call, which will feature a live question-and-answer segment, is set for 4:30 PM ET (22:30 CET). This interactive session offers an invaluable opportunity for investors to hear directly from key executives at MDxHealth, providing insights into the company’s performance and strategic direction.
Who Will Speak?
The session will be led by the Chief Executive Officer, Michael K. McGarrity, alongside the Chief Financial Officer, Ron Kalfus. Together, they will discuss the company's achievements over the past year, touching upon significant developments in their diagnostic solutions and operational advancements.
How to Join the Call?
Investors interested in participating can dial in via several local numbers, ensuring accessibility for a global audience. For instance, participants from the United States can connect through 1-844-825-9789, while those in Belgium can use 0800 38 961. Other numbers include 0800 94 94 506 for the Netherlands and 0808 238 9064 for the UK.
Accessing the Webcast
For those unable to join by phone, a webcast will also be available. Participants are encouraged to log in 15 minutes before the start time to ensure a smooth experience. Following the event, a replay will be accessible on the MDxHealth website, allowing a review of the insights shared during the call.
About MDxHealth
MDxHealth specializes in offering actionable molecular information, which is crucial for personalizing patient diagnoses and treatments. With its state-of-the-art tests, the company utilizes proprietary genomic and epigenetic technologies to aid healthcare providers in the diagnosis of urologic cancers and related diseases.
Global Presence
Headquartered in Irvine, California, MDxHealth operates laboratories in Plano, Texas, and maintains its European base in Herstal, Belgium. As a leader in precision diagnostics, the firm is committed to enhancing patient care through innovative solutions backed by robust research and development.
Contact Information
For further inquiries, MDxHealth can be contacted via email at info@mdxhealth.com. The company also has a dedicated line for investor relations, which can be reached at +1 949 271 9223, in addition to their IR email at ir@mdxhealth.com.
Frequently Asked Questions
What are the key highlights expected from the conference call?
The call will focus on MDxHealth's financial performance and corporate updates, discussing growth strategies and future outlook.
When is the conference call scheduled?
The conference call is set for February 26, 2025, at 4:30 PM ET.
Who are the main speakers during the call?
Michael K. McGarrity, CEO, and Ron Kalfus, CFO, will be leading the call.
How can I access the webcast?
The webcast can be accessed through the MDxHealth website, with participants advised to join 15 minutes early.
What is MDxHealth's focus as a company?
MDxHealth is dedicated to precision diagnostics that provide patients with personalized treatment options based on advanced molecular information.
